INSIGHTS ON CLINICAL TRIAL PARTNERING

  • When Your Protocol Includes Ocular Endpoints
    4/6/2026

    Standardizing ocular endpoint execution reduces participant dropout and eliminates data variability. Specialized oversight secures clinical timelines and ensures high-quality, submission-ready data.

  • From Legacy To Lifeline: Advancing Rare Disease Care
    6/13/2025

    Learn about inspiring figures who lived with rare diseases, get a look at today’s rare disease research, and see how we support patients around the world in this eBook.

  • The Real Power Of Digital Payments In Clinical Trials
    10/8/2025

    Digital payments streamline clinical trials by reducing site burden, improving patient experience, eliminating manual delays, and delivering cleaner data across global studies.

  • Building A Gold Standard Trial Experience In Japan
    4/4/2025

    Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.

  • A Guide To Patient Reimbursements And Payments
    9/13/2024

    Delayed or inadequate payments can harm patient retention and site efficiency. Learn how sponsors can mitigate financial toxicity, streamline reimbursement, and ensure a positive experience for all involved.

CLINICAL TRIAL PARTNERING SOLUTIONS

  • Maximize growth with strategic site selection and incentives advisory that help reduce project costs and optimize expansion, unlocking long-term business value.

  • Choosing the right vendor at trial launch impacts costs, timelines, data integrity, and patient experience — yet vendor selection in clinical research remains fundamentally broken today.

  • Discover a debit card designed for clinical trials, providing participants with fast, reliable payments and giving sites and sponsors clear systems that help minimize burden and improve retention.

  • With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.

  • Successfully navigating the complexities of bladder cancer research means mastering specialized delivery methods, managing supply constraints, and leveraging deep site relationships across all phases.